Search

Catherine J Hardalo

from San Diego, CA
Age ~62
Get Report
Also known as:
Catherine Dr Hardalo, Catherin J Davis, Catherine D
Phone and address:
12650 Carmel Country Rd UNIT 116, San Diego, CA 92130
(858) 720-1470
Related to:
Helena Davis, 71
Connected to:
Jim Hardaman, 93Nigel R Hardaman, 38Zora B Hardamon, 71Guadalupe S Hardan, 62Nadia F Hardan, 49Karim K Hardani, 70Elizabeth H Hardardt, 29Kevin M Hardardt, 65Matthew E Hardardt, 34Thomas Hardardt, 31

Catherine Hardalo Phones & Addresses

  • 12650 Carmel Country Rd UNIT 116, San Diego, CA 92130 (858) 720-1470
  • Bar Harbor, ME
  • Morristown, NJ
  • Netcong, NJ
  • East Haven, CT
  • Morgan, NJ

Interests

career opportunities, expertise requests...

Industries

Pharmaceuticals

Resumes

Resumes

Catherine Hardalo Photo 1

Vp, Clinical Development At Cadence Pharmaceuticals

View page
Location:
Greater San Diego Area
Industry:
Pharmaceuticals
Experience:
Cadence Pharmaceuticals (Public Company; CADX; Pharmaceuticals industry): VP, Clinical Development,  (April 2007-Present) Schering-Plough (Public Company; 10,001+ employees; MRK; Pharmaceuticals industry): Senior Director, Clinical Research, Anti Infectives,  ...

Business Records

Name / Title
Company / Classification
Phones & Addresses
Catherine Hardalo
CTO
Cadence Pharmaceuticals
Medicinals and Botanicals
12730 High Blf Dr STE 410, San Diego, CA 92130
(858) 436-1400

Publications

Us Patents

Particulate-Stabilized Injectable Pharmaceutical Compositions Of Posaconazole

View page
US Patent:
20060160823, Jul 20, 2006
Filed:
Dec 14, 2005
Appl. No.:
11/300677
Inventors:
Sydney Ugwu - Gurnee IL, US
Varda Sandweiss - New York NY, US
Catherine Hardalo - Morristown NJ, US
Roberta Hare - Gillette NJ, US
Gopal Krishna - North Brunswick NJ, US
Zaiqi Wang - Edison NJ, US
Marco Taglietti - Watchung NJ, US
International Classification:
A61K 31/496
US Classification:
514254070
Abstract:
The present invention provides formulations useful for treating infections, in particular, formulations that include the active pharmaceutical ingredient Posaconazole in an injectable suspension of particles that is stable when subjected to terminal sterilization. Preferred median particle sizes of between 1.5 and 3.0 microns are found to result in superior pharmacokinetic characteristics, such as those displayed below.

Particulate-Stabilized Injectable Pharmacutical Compositions Of Posaconazole

View page
US Patent:
20090226527, Sep 10, 2009
Filed:
Mar 3, 2009
Appl. No.:
12/380790
Inventors:
Sydney Ugwu - Gurnee IL, US
Varda E. Sandweiss - New York NY, US
Catherine Hardalo - Morristown NJ, US
Roberta S. Hare - Gillette NJ, US
Gopal Krishna - North Brunswick NJ, US
Zaiqi Wang - Edison NJ, US
Marco Taglietti - Watchung NJ, US
International Classification:
A61K 9/14
A61P 31/10
US Classification:
424489
Abstract:
The present invention provides formulations useful for treating infections, in particular, formulations that include the active pharmaceutical ingredient Posaconazole in an injectable suspension of particles that is stable when subjected to terminal sterilization. Preferred median particle sizes of between 1.5 and 3.0 microns are found to result in superior pharmacokinetic characteristics-displayed in FIG.

Particulate-Stabilized Injectable Pharmacutical Compositions Of Posaconazole

View page
US Patent:
20060009469, Jan 12, 2006
Filed:
May 27, 2005
Appl. No.:
11/140294
Inventors:
Sydney Ugwu - Gurnee IL, US
Varda Sandweiss - Forest Hills NY, US
Catherine Hardalo - Morristown NJ, US
Roberta Hare - Gillette NJ, US
Gopal Krishna - North Brunswick NJ, US
Zaiqi Wang - Edison NJ, US
International Classification:
A61K 31/496
US Classification:
514254070
Abstract:
The present invention provides formulations useful for treating infections, in particular, formulations that include the active pharmaceutical ingredient posaconazole in an injectable suspension that is stable when subjected to terminal steam sterilization.
Control profile
Catherine J Hardalo from San Diego, CA, age ~62 Get Report